Table 4 The ORs for abnormal levels of lipid-related indices separated by sex

 Q1

1

1

1

1

 Q2

1.06 (0.96–1.17)

0.06

1.01 (0.86–1.19)

0.01

0.95 (0.87–1.05)

− 0.05

0.83 (0.69–1.00)

− 0.18

 Q3

1.31 (1.19–1.46)”

0.27

1.04 (0.89–1.23)

0.04

0.99 (0.90–1.10)

− 0.01

0.89 (0.74–1.07)

− 0.12

 Q4

1.48 (1.33–1.64)”

0.39

1.18 (1.00–1.40)’

0.17

1.07 (0.97–1.19)

0.07

0.74 (0.62–0.90)’

−0.30

 Q1

1

1

1

1

 Q2

1.05 (0.95–1.15)

0.05

1.11 (0.94–1.29)

0.10

0.91 (0.83–1.00)’

− 0.10

0.94 (0.78–1.12)

− 0.06

 Q3

1.01 (0.92–1.11)

0.01

1.03 (0.88–1.22)

0.03

0.87 (0.79–0.95)’

− 0.14

0.92 (0.76–1.11)

−0.08

 Q4

1.07 (0.97–1.17)

0.06

1.04 (0.88–1.22)

0.04

0.86 (0.79–0.95)’

− 0.15

0.81 (0.66–0.98)’

− 0.22

 Q1

1

1

1

1

 Q2

0.91 (0.83–1.00)’

−0.10

1.01 (0.86–1.18)

0.01

0.83 (0.76–0.91)”

−0.19

0.94 (0.78–1.14)

− 0.06

 Q3

0.89 (0.81–0.98)’

− 0.11

0.93 (0.79–1.09)

− 0.08

0.85 (0.77–0.93)’

− 0.17

0.88 (0.73–1.06)

− 0.13

 Q4

0.80 (0.73–0.88)”

−0.22

0.98 (0.83–1.15)

− 0.02

0.80 (0.73–0.88)”

− 0.22

0.85 (0.71–1.03)

− 0.16

 Q1

1

1

1

1

 Q2

0.90 (0.81–0.98)’

− 0.11

0.92 (0.78–1.08)

− 0.08

0.97 (0.88–1.06)

− 0.03

0.97 (0.80–1.17)

− 0.03

 Q3

0.97 (0.88–1.06)

−0.03

0.94 (0.80–1.10)

− 0.06

0.88 (0.81–0.97)’

− 0.12

0.92 (0.76–1.11)

−0.09

 Q4

0.85 (0.77–0.93)’

− 0.17

0.86 (0.73–1.01)

− 0.16

0.85 (0.78–0.94)’

− 0.16

0.92 (0.76–1.12)

− 0.08

 Q1

1

1

1

1

 Q2

1.09 (0.99–1.20)

0.09

0.99 (0.85–1.17)

−0.01

1.12 (1.02–1.23)’

0.11

1.07 (0.88–1.29)

0.07

 Q3

1.10 (1.00–1.21)

0.09

0.96 (0.82–1.13)

−0.04

1.10 (1.00–1.21)’

0.10

0.98 (0.81–1.19)

− 0.02

 Q4

1.10 (1.00–1.21)

0.10

0.88 (0.75–1.03)

−0.13

1.21 (1.10–1.33)”

0.19

0.96 (0.79–1.16)

− 0.04

Low HDL-C

High LDL-C

Male

Female

Male

Female

OR (95% CI)

β

OR (95% CI)

β

OR (95% CI)

β

OR (95% CI)

β

 Q1

1

1

1

1

 Q2

0.95 (0.86–1.05)

−0.05

0.97 (0.83–1.14)

− 0.03

1.09 (0.99–1.19)

0.08

0.92 (0.79–1.08)

−0.08

 Q3

0.80 (0.72–0.89)”

− 0.23

0.96 (0.82–1.14)

−0.04

1.20 (1.09–1.32)”

0.18

0.98 (0.84–1.15)

− 0.02

 Q4

0.73 (0.65–0.81)”

−0.32

0.96 (0.81–1.13)

− 0.05

1.24 (1.13–1.36)”

0.22

1.19 (1.01–1.39)’

0.17

 Q1

1

1

1

1

 Q2

0.97 (0.88–1.07)

−0.03

0.89 (0.76–1.05)

− 0.12

1.05 (0.96–1.16)

0.05

1.11 (0.95–1.29)

0.10

 Q3

1.03 (0.93–1.14)

0.03

0.86 (0.73–1.02)

−0.15

1.14 (1.04–1.25)’

0.13

0.99 (0.84–1.16)

−0.01

 Q4

1.04 (0.94–1.15)

0.04

0.93 (0.79–1.09)

−0.08

1.17 (1.02–1.28)’

0.15

1.09 (0.93–1.28)

0.08

 Q1

1

1

1

1

 Q2

0.89 (0.80–0.98)’

−0.12

0.88 (0.75–1.04)

− 0.12

0.95 (0.87–1.04)

−0.05

1.02 (0.87–1.20)

0.02

 Q3

0.91 (0.83–1.01)

−0.09

0.91 (0.77–1.07)

−0.10

0.93 (0.85–1.02)

− 0.07

0.93 (0.79–1.09)

−0.08

 Q4

0.94 (0.85–1.03)

−0.07

0.89 (0.75–1.04)

− 0.12

0.89 (0.81–0.98)’

− 0.11

0.86 (0.74–1.02)

− 0.15

 Q1

1

1

1

1

 Q2

1.07 (0.97–1.19)

0.07

0.97 (0.82–1.14)

−0.03

0.96 (0.88–1.06)

− 0.04

0.89 (0.76–1.04)

− 0.12

 Q3

1.09 (0.98–1.21)

0.09

1.00 (0.85–1.17)

0.00

1.04 (0.95–1.14)

0.04

0.90 (0.77–1.06)

−0.10

 Q4

1.08 (0.98–1.20)

0.08

1.09 (0.92–1.28)

0.09

0.91 (0.83–1.00)’

− 0.10

0.89 (0.76–1.05)

− 0.11

 Q1

1

1

1

1

 Q2

1.03 (0.93–1.14)

0.03

0.99 (0.84–1.17)

−0.01

1.10 (1.00–1.20)

0.09

1.04 (0.89–1.23)

0.04

 Q3

1.00 (0.90–1.11)

0.00

0.97 (0.83–1.15)

−0.03

1.05 (0.96–1.16)

0.05

0.98 (0.84–1.15)

−0.02

 Q4

1.05 (0.95–1.17)

0.05

1.03 (0.88–1.22)

0.03

1.00 (0.91–1.09)

−0.01

1.01 (0.86–1.19)

0.01